Localised ALK-positive histiocytosis in lung with EML4::ALK fusion

被引：3
|
作者：
Zou, Long [1 ]
Lu, Tao [1 ]
Li, Mei [1 ]
Wang, Anqi [2 ]
Zhang, Zixin [2 ]
Pan, Boju [1 ]
Sun, Jian [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med Res Ctr, Beijing, Peoples R China
来源：
PATHOLOGY | 2024年 / 56卷 / 04期
关键词：
D O I：
10.1016/j.pathol.2023.09.014
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：604 / 606
页数：3
相关论文
共 50 条
  • [21] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [22] Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
    Lin, Jessica J.
    Zhu, Viola W.
    Yoda, Satoshi
    Yeap, Beow Y.
    Schrock, Alexa B.
    Dagogo-Jack, Ibiayi
    Jessop, Nicholas A.
    Jiang, Ginger Y.
    Le, Long P.
    Gowen, Kyle
    Stephens, Philip J.
    Ross, Jeffrey S.
    Ali, Siraj M.
    Miller, Vincent A.
    Johnson, Melissa L.
    Lovly, Christine M.
    Hata, Aaron N.
    Gainor, Justin F.
    Iafrate, Anthony J.
    Shaw, Alice T.
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1199 - +
  • [23] Tacklng the EML4/ALK Fusion Oncogenes in Murine Models.
    Hawes, J.
    Vilimas, T.
    Collins, K.
    Kozlov, S.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 : S44 - S44
  • [24] ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system
    Lucas, Calixto-Hope G.
    Gilani, Ahmed
    Solomon, David A.
    Liang, Xiayuan
    Maher, Ossama M.
    Chamyan, Gabriel
    Kleinschmidt-Demasters, Bette K.
    Perry, Arie
    ACTA NEUROPATHOLOGICA, 2019, 138 (02) : 335 - 337
  • [25] ALK-Positive Histiocytosis with KIF5B-ALK Fusion in the Central Nervous System
    Lucas, Calixto-Hope
    Gilani, Ahmed
    Solomon, David
    Liang, Xiayuan
    Maher, Ossama
    Chamyan, Gabriel
    Kleinschmidt-DeMasters, Bette
    Perry, Arie
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 562 - 563
  • [26] ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system
    Calixto-Hope G. Lucas
    Ahmed Gilani
    David A. Solomon
    Xiayuan Liang
    Ossama M. Maher
    Gabriel Chamyan
    Bette K. Kleinschmidt-Demasters
    Arie Perry
    Acta Neuropathologica, 2019, 138 : 335 - 337
  • [27] Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
    Bearz, Alessandra
    Martini, Jean-Francois
    Jassem, Jacek
    Kim, Sang-We
    Chang, Gee-Chen
    Shaw, Alice T.
    Shepard, Deborah A.
    Dall'O, Elisa
    Polli, Anna
    Thurm, Holger
    Zalcman, Gerard
    Campelo, Maria Rosario Garcia
    Penkov, Konstantin
    Hayashi, Hidetoshi
    Solomon, Benjamin J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : 1581 - 1593
  • [28] Two novel EML4-ALK fusion variants involving EML4 exon 17 identified in lung cancer
    Li, Hai-Rong
    Sanders, Heather R.
    Sferruzza, Anthony D.
    Novic, Connie
    Meloni-Ehrig, Aurelia M.
    Albitar, Maher
    CANCER RESEARCH, 2010, 70
  • [29] ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant
    Holsten, Till
    Bronsema, Annika
    Sturm, Dominik
    Sahm, Felix
    Rutkowski, Stefan
    Schuller, Ulrich
    Wossmann, Wilhelm
    Kordes, Uwe R.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [30] A Novel EML4-ALK Variant Exon 6 of EML4 Fused to Exon 19 of ALK
    Penzel, Roland
    Schirmacher, Peter
    Warth, Arne
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1198 - 1199
12345